Bookmark Menu


Mgodi, NM, Kelly C, Gati B, et al. Factors Associated with Bone Mineral Density in Health African Women. Arch Osteoporos. 2015;10:206.

View » MTN 003B

Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, et al. (2011) Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365(6): 493-505.

View » HPTN 052

Miller S, Eergel EF, El Ayadi AM, Gibbons L, Butrick EA, et al. (2013) Non-pneumatic anti-shock garment (NASG), a first-aid device to decrease maternal mortality from obstetric hemorrhage: a cluster randomized trial. PloS One; 8(10): e76477.

View » Non-Pneumatic Anti-Shock Garment (NASG), A First-Aid Device to Decrease Maternal Mortality from Obstetric Hemorrhage: A Cluster Randomized Trial

Fuscus SA, Cu-Uvin S, Tilahun Eshete A, Hughes MD, Bao Y, et al. (2013) Changes in HIV-1 Subtypes B and C Gential Tract RNA in Women and Men After Initiation of Antiretroviral Therapy. Clin Infec Dis 57(2): 290-297.

View » A5185s

Baeten JM, Planee-Phillips T, Brown ER, et. al. Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women. N Engl J Med. 2016 Dec 1;375(22):2121-2132

View » MTN 020 (ASPIRE)

Musara P, Montgomery ET, Mgodi NM, et al. How Presentation of Drug Detection Results Changed Reports of Product Adherence in South Africa, Uganda, and Zimbabwe. AIDS Behav. 2017 Jan 21.

View » MTN 003D

Gomani P, Matubu AT, Mujuru HA et al. (2015) Hematological and Biochemical Laboratory Reference Intervals for Zimbabwean Adolescents. Clin. Lab; 2015; 61:101-111

View » Establishment of Laboratory Reference Values for Harare, Chitungwiza, and Mutoko

Montgomery ET, Woodsong C, Musara P, Cheng H, Chipato T, et al. (2010) An acceptability and safety study of the Duet cervical barrier and gel delivery system in Zimbabwe. J Int AIDS Soc; 13:30.

View » An Acceptability and Safety Study of the Duet® Cervical Barrier and Gel Delivery System in Zimbabwe

Fritz K, McFarland W, Wyrod R, Chasakara C, Makumbe K, et al. (2011) Evaluation of a peer network-based sexual risk reduction intervention for men in beer halls in Zimbabwe: results from a randomized controlled trial. AIDS Behav; 15(8): 1732-44.

View » Linking Alcohol Use with HIV Risk Behavior and HIV Prevalence Among Beer Hall Patrons in Harare, Zimbabwe

Minnis AM, Muchini A, Shiboski S, Mwale M, Morrision C, Chipato T, et al. (2007) Audio computer-assisted self-interviewing in reproductive health research: reliability assessment among women in Harare, Zimbabwe. Contraception; 75 (1): 59-65.

View » The Reliability of ACASI Data Collection in Zimbabwe

Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, et al. (2007) Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomized controlled trial. Lancet; 370(9583): 251-61.

View » Diaphragm and Lubricant Gel for Prevention of HIV Acquisition in Southern African Women: A Randomized, Controlled Trial (MIRA)

Chidzonga MM, Mwale M, Malvin K, Martin K, Greenspan JS, et al. (2008) Oral candidiasis as a marker of HIV disease progression among Zimbabwean women. J Acquir Immune Defic Syndr; 47(5): 579-84.

View » Oral Candidiasis Marker of HIV-Disease Progression Among Zimbabwean Women

Morrison CS, Richardson BA, Mmiro F, Chipato T, Celentano DD, et al. (2007) Hormonal contraception and the risk of HIV acquisition. AIDS; 21(1): 85-95.

View » Hormonal Contraception and the Risk of HIV-1 Acquisition Among Young Women in Uganda and Zimbabwe

van der Straten A, Napierala S, Cheng H, Mauck C, Depineres T, et al. (2007) A randomized controlled safety trial of the diaphragm and cellulose sulfate microbicide gel in sexually active women in Zimbabwe. Contraception; 76(5): 389-99.

View » A Randomized, Controlled Safety Trial of the Diaphragm and Cellulose Sulfate Microbicide Gel in Sexually Active Women in Zimbabwe

Chirenje ZM, Chipato T, Kasule J, Rusakaniko S (1999). Visual inspection of the cervix as a primary means of cervical cancer screening: results of a pilot study. Cent Afr J Med; 45(2): 30-3.

View » Visual Inspection of the Cervix as a Primary Means of Cervical Cancer Screening: Results of a Pilot Study

Abdool Karim SS, Richardson BA, Ramjee G, Hoffman IF, Chirenje ZM, et al. (2011) Safety and effectiveness of BufferGel and 0.5% PRO 2000 gel for prevention of HIV infection in women. AIDS; 25(7): 957-66.

View » HPTN/MTN 035

van De Wilgert J, Fullem A, Kelly C, Mehendale S, Rugpao S, et al. (2001) Phase 1 trial of the microbicide BufferGel: safety results from four international sites. J Acquir Immune Defic Syndr; 26(1): 21-7.

View » Phase I Trial of the Topical Microbicide BufferGel

Violari A, Lindsey JC, Hughes MD, Mujuro HA, Barlow-Mosha L, et al. (2012) Nevirapine versus rtonavir-boosted lopinavir for HIV-infected children. N Engl J Med; 366 (25): 2380-9.

View » P1060

Coovadia HM, Brown ER, Fowler ER, Chipato T, Moodley D, et al. (2012) Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomized, double-blind, placebo-controlled trial. Lancet; 379 (9812): 221-8.


Celum C, Wald A, Hughes J, Sanchez J, Reid S, et al. (2008) Effect of acyclovir on HIV-1 acquisition on herpes simplex virus 2 seropositive women and men who have sex with men: a randomized, double-blind, placebo-controlled trial. Lancet 371(9630): 2109-19.

View » HPTN 039

Shetty AK, Coovadia HM, Mirochnick MM, Maldonado Y, Mofenson LM, et al. (2003) Safety and trough concentrations of nevirapine phrophylaxis given daily, twice daily, or weekly in breast-feeding infants from birth to 6 months. J Acquir Immune Defic Synd; 34(5): 482-90.

View » HIVNET/HPTN 023

Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, et al. (2011) Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med 365(16): 1482-91.

View » A5221

Lockman S, Hughes M, Sawe F, Zheng Y, McIntyre J, Chipato T, et al. (2012) Nevirapine-versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial. PLos Med 9(6): e1001236.

View » A5208

Robertson K, Jiang H, Kumwenda J, Supparatpinyo K, Evans S, et al. (2012) Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study A5199, the International Neurological Study. Clin Infect Dis 55(6): 868-76.

View » A5199

Nielsen-Saines K, Komarow L, Cu-Uvin S, Jourdain G, Klingman KL, et al. (2012) Infant outcomes after maternal antiretroviral exposure in resource-limited settings. Pediatrics 219(6): e1525-32.

View » A5190/P1054

Kumwenda N, Hoffman I, Chirenje ZM, Kelly C, Coletti A, et al. (2006) HIV incidence among women of reproductive age in Malawi and Zimbabwe. Sex Transm Dis; 33(11): 646-51


Robertson K, Jiang H, Kumwenda J, Supparatpinyo K, Evans S, et al. (2012) Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study A5199, the International Neurological Study. Clin Infect Dis 55(6): 868-76.

View » A5199

Campbell TB, Smeaton LM, Kumarasamy N, Flanigan T, Klingman KL, et al. (2012) Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings. PLoS Med 9(8): e1001290.

View » A5175

List of all current and completed research